SPICA THERAPEUTICS
The computed 12-month bankruptcy probability of SPICA THERAPEUTICS is 0.4% (very low). The 2025 annual accounts show equity of €6.16M and a net result of €-2.73M. Its solvency ranks better than 81% of 84 sector peers (fiscal year 2025). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €6.16M |
| Net result | €-2.73M |
| Staff (FTE) | 0.7 |
| Better than sector | 81% |
Mixed profile: strong on solvency, weaker on profitability.
Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 82.6% | 46.6% | |
| Net result | €-2.73M | €15k | |
| Equity | €6.16M | €86k | |
| Gross operating margin | €-1.01M | €44k | |
| Total assets | €7.45M | €251k |
| Fiscal year | 2025 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €-1.04M |
| Net profit | €-2.73M |
| Cash flow | €-990k |
| Staff costs | €37k |
| Income taxes | €-59k |
| Dividends | - |
| Total assets | €7.45M |
| Equity | €6.16M |
| Debt | €1.30M |
| of which ≤ 1y | €1.16M |
| of which > 1y | - |
| Working capital | €1.31M |
| Employees (FTE) | 0.7 |
| 2025 | |
|---|---|
| Current ratio | 2.14 |
| Quick ratio | 2.14 |
| Working capital ratio | 17.6% |
| Solvency | 82.6% |
| Debt / equity | 0.21 |
| Long-term debt ratio | - |
| Interest coverage | -246.03 |
| Gross margin | - |
| Net margin | - |
| ROA | -36.7% |
| ROE | -44.4% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (22 line items)
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €7.45M |
| Fixed assets | 21/28 | €4.99M |
| Intangible fixed assets | 21 | €96k |
| Tangible fixed assets | 22/27 | €7k |
| Financial fixed assets | 28 | €4.88M |
| Current assets | 29/58 | €2.47M |
| Amounts receivable within one year | 40/41 | €1.13M |
| Cash & bank | 54/58 | €997k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €7.45M |
| Equity | 10/15 | €6.16M |
| Contributions / capital | 10/11 | €8.89M |
| Accumulated profits (losses) | 14 | €-2.73M |
| Amounts payable | 17/49 | €1.30M |
| Amounts payable within one year | 42/48 | €1.16M |
| Trade debts payable within one year | 44 | €1.15M |
| Income statement | ||
| Gross operating margin | 9900 | €-1.01M |
| Operating result | 9901 | €-2.79M |
| Financial charges | 65 | €4k |
| Result before taxes | 9903 | €-2.79M |
| Income taxes | 67/77 | €-59k |
| Net result for the period | 9904 | €-2.73M |
| Result to be appropriated | 9905 | €-2.73M |
-
BIOSKILLSLegal entityDirector· perm. rep.: VAN HEUSDEN Jimmy Arnold VivianeState Gazette act 25336646 (11-06-2025)Current27-05-2025 → present
-
DEBORA DUMONT MANAGEMENT COMPANYLegal entityDirector· perm. rep.: DUMONT Debora Catharina DominiqueState Gazette act 25336646 (11-06-2025)Current27-05-2025 → present
-
Impala ConsultingLegal entityDirector· perm. rep.: DEMOULIN Alexander BharmalState Gazette act 25336646 (11-06-2025)Current27-05-2025 → present
-
PARTICIPATIEMAATSCHAPPIJ VLAANDERENLegal entityDirector· perm. rep.: DE TAEY Bart MariaState Gazette act 25336646 (11-06-2025)Current27-05-2025 → present
-
QBIC VENTURE PARTNERS IIILegal entityDirector· perm. rep.: LEURIDAN StevenState Gazette act 25336646 (11-06-2025)Current27-05-2025 → present
-
Current12-05-2025 → present
Show 2 more sitting directors
-
Impala ConsultingLegal entityDirector· perm. rep.: Alexander DemoulinState Gazette act 25060417 (12-05-2025)Current12-05-2025 → present
-
TRIANGULATE GmbHLegal entityDirector· perm. rep.: RUSH James StuartState Gazette act 25336646 (11-06-2025)Current12-05-2025 → present
2 events
- 27-05-2025 Appointed· Director
- 12-05-2025 Appointed· Director
| NACE primary | Speur- en ontwikkelingswerk op biotechnologisch gebied(72101) |
| Legal form | Public limited company(014) |
| Incorporation | 26-08-2024 |
| Status | Active |
| Postal code | 2600 |
Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11303B0445/00F008 | Flanders | 2,372 m² | 1 · 792 m² | 23.9 m · 7 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Of the 8 Belgian State Gazette acts we know for this company, 1 has been read. The other 7 have not been read yet: what they contain is neither established nor disproved here.
07-08-2026 Act object · Notarial deed · General meeting · Capital increase
- Act object: ONTSLAGEN, BENOEMINGEN, KAPITAAL, AANDELEN · SPICA THERAPEUTICS
- Publication: 07/08/2026 · SPICA THERAPEUTICS
- Filing: 05-08-2026 · SPICA THERAPEUTICS
- Notarial deed: 29-07-2026 · SPICA THERAPEUTICS
- General meeting: 29-07-2026 · SPICA THERAPEUTICS
- Capital increase: after: 14.987.251,44 EUR, delta: 4.100.000,00 EUR, amount: 14987251.44, before: 10.887.251,44 EUR, paid_up: 100%, payment: in geld, currency: EUR, shares_issued: 83.128 Seed aandelen · SPICA THERAPEUTICS
- Bank account: bank: BNP Paribas Fortis, date: 27 juli 2026, number: BE35 0020 3420 0437 · SPICA THERAPEUTICS
- Capital: amount: 14987251.44, currency: EUR, shares_total: 318.982 · SPICA THERAPEUTICS
- Share issue: type: Anti-Dilutie Inschrijvingsrechten, count: 15, description: Full Seed anti-dilutie Inschrijvingsrechten · SPICA THERAPEUTICS
- Capital increase: type: conditional, shares: Seed Aandelen, currency: EUR, condition: uitoefening van de anti-dilutie Inschrijvingsrechten, max_amount: vermenigvuldiging van het aantal uitgeoefende Full Seed anti-dilutie Inschrijvingsrechten met de uitoefeningsprijs · SPICA THERAPEUTICS
- Share issue: plan: Aandelenoptieplan 2026 BIS, type: ESOP Inschrijvingsrechten, count: 24.717, description: ESOP 2026 BIS Inschrijvingsrechten · SPICA THERAPEUTICS
- Capital increase: type: conditional, shares: maximaal 24.717 Gewone Aandelen, currency: EUR, condition: uitoefening van de 2026 BIS ESOP Inschrijvingsrechten, max_amount: vermenigvuldiging van het aantal uitgeoefende 2026 BIS ESOP Inschrijvingsrechten met de uitoefeningsprijs · SPICA THERAPEUTICS
- Officer resignation: role: bestuurder · Impala Consulting Comm.V
- Officer appointment: role: bestuurder, term: 6 jaar, start_date: 2026-07-29 · ALTHUARDE LIFE SCIENCES
- Permanent representative: role: Investeerder Bestuurder · Roderick Verhelst
- Mandate compensation: onbezoldigd · ALTHUARDE LIFE SCIENCES
- Subscription right cancellation: type: Anti-Dilutie Inschrijvingsrechten, count: 15, status: niet-toegekend, issued_date: 27 mei 2025 · SPICA THERAPEUTICS
- Subscription right cancellation: type: ESOP Inschrijvingsrechten, count: 15.481, status: niet-toegekend · SPICA THERAPEUTICS
- Board authorization: plan: Aandelenoptieplan 2026 BIS, scope: vaststelling identiteit begunstigden, aantal aangeboden 2026 BIS ESOP Inschrijvingsrechten en uitoefenprijs, mandatary: raad van bestuur · SPICA THERAPEUTICS
Technical details
{
"facts": [
{
"type": "act_object",
"quote": "Onderwerp akte : ONTSLAGEN, BENOEMINGEN, KAPITAAL, AANDELEN",
"value": "ONTSLAGEN, BENOEMINGEN, KAPITAAL, AANDELEN",
"object": null,
"subject": "e1"
},
{
"date": "2026-08-07",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 07/08/2026",
"value": "07/08/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-08-05",
"type": "filing",
"quote": "Neergelegd 05-08-2026",
"value": "05-08-2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-29",
"type": "notarial_deed",
"quote": "Op heden, negenentwintig juli tweeduizend zesentwintig. (...) Voor Tim CARNEWAL, notaris te Brussel",
"value": "29-07-2026",
"object": "e6",
"subject": "e1"
},
{
"date": "2026-07-29",
"type": "general_meeting",
"quote": "Op heden, negenentwintig juli tweeduizend zesentwintig. (...) WORDT GEHOUDEN de buitengewone algemene vergadering",
"value": "29-07-2026",
"object": null,
"subject": "e1"
},
{
"type": "capital_increase",
"quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 4.100.000,00 EUR, om het van 10.887.251,44 EUR te brengen op 14.987.251,44 EUR, door inbreng in geld en met de uitgifte van 83.128 Seed aandelen",
"value": {
"after": "14.987.251,44 EUR",
"delta": "4.100.000,00 EUR",
"amount": 14987251.44,
"before": "10.887.251,44 EUR",
"paid_up": "100%",
"payment": "in geld",
"currency": "EUR",
"shares_issued": "83.128 Seed aandelen"
},
"amount": 4100000.0,
"object": null,
"subject": "e1",
"currency": "EUR",
"_value_raw": {
"after": "14.987.251,44 EUR",
"delta": "4.100.000,00 EUR",
"before": "10.887.251,44 EUR",
"paid_up": "100%",
"payment": "in geld",
"shares_issued": "83.128 Seed aandelen"
}
},
{
"date": "2026-07-27",
"type": "bank_account",
"quote": "gestort op een bijzondere rekening met nummer BE35 0020 3420 0437 op naam van de Vennootschap bij BNP Paribas Fortis, zoals blijkt uit een attest afgeleverd door deze kredietinstelling op 27 juli 2026",
"value": {
"bank": "BNP Paribas Fortis",
"date": "27 juli 2026",
"number": "BE35 0020 3420 0437"
},
"object": null,
"subject": "e1"
},
{
"type": "capital",
"quote": "Het kapitaal van de vennootschap bedraagt veertien miljoen negenhonderdzevenentachtigduizend tweehonderdeenenvijftig euro vierenveertig cent (14.987.251,44 EUR). ... vertegenwoordigd door driehonderd achttienduizend negenhonderd twee\u00EBntachtig (318.982) aandelen ... waarvan: - honderdveertienduizend tweehonderdenvijf (114.205) Gewone Aandelen; en - tweehonderdvierduizend zevenhonderd zevenenzeventig (204.777) Seed Aandelen.",
"value": {
"amount": 14987251.44,
"currency": "EUR",
"breakdown": [
"114.205 Gewone Aandelen",
"204.777 Seed Aandelen"
],
"shares_total": "318.982"
},
"amount": 14987251.44,
"object": null,
"subject": "e1",
"currency": "EUR",
"_value_raw": {
"amount": "14.987.251,44 EUR",
"breakdown": [
"114.205 Gewone Aandelen",
"204.777 Seed Aandelen"
],
"shares_total": "318.982"
}
},
{
"type": "share_issue",
"quote": "De vergadering beslist 15 Full Seed anti-dilutie Inschrijvingsrechten uit te geven",
"value": {
"type": "Anti-Dilutie Inschrijvingsrechten",
"count": "15",
"description": "Full Seed anti-dilutie Inschrijvingsrechten"
},
"object": null,
"subject": "e1"
},
{
"type": "capital_increase",
"quote": "De vergadering beslist - onder de opschortende voorwaarde en in de mate van de uitoefening van de anti-dilutie Inschrijvingsrechten \u2013 over te gaan tot een kapitaalverhoging in geld",
"value": {
"type": "conditional",
"shares": "Seed Aandelen",
"currency": "EUR",
"condition": "uitoefening van de anti-dilutie Inschrijvingsrechten",
"max_amount": "vermenigvuldiging van het aantal uitgeoefende Full Seed anti-dilutie Inschrijvingsrechten met de uitoefeningsprijs"
},
"object": null,
"subject": "e1",
"_value_raw": {
"type": "conditional",
"shares": "Seed Aandelen",
"condition": "uitoefening van de anti-dilutie Inschrijvingsrechten",
"max_amount": "vermenigvuldiging van het aantal uitgeoefende Full Seed anti-dilutie Inschrijvingsrechten met de uitoefeningsprijs"
}
},
{
"type": "share_issue",
"quote": "De vergadering beslist 24.717 ESOP 2026 BIS Inschrijvingsrechten uit te geven in het kader van het \u201CAandelenoptieplan 2026 BIS\u201D",
"value": {
"plan": "Aandelenoptieplan 2026 BIS",
"type": "ESOP Inschrijvingsrechten",
"count": "24.717",
"description": "ESOP 2026 BIS Inschrijvingsrechten"
},
"object": null,
"subject": "e1"
},
{
"type": "capital_increase",
"quote": "De vergadering beslist - onder de opschortende voorwaarde en in de mate van de uitoefening van de 2026 BIS ESOP Inschrijvingsrechten \u2013 over te gaan tot een kapitaalverhoging in geld ... met uitgifte van maximaal 24.717 Gewone Aandelen",
"value": {
"type": "conditional",
"shares": "maximaal 24.717 Gewone Aandelen",
"currency": "EUR",
"condition": "uitoefening van de 2026 BIS ESOP Inschrijvingsrechten",
"max_amount": "vermenigvuldiging van het aantal uitgeoefende 2026 BIS ESOP Inschrijvingsrechten met de uitoefeningsprijs"
},
"object": null,
"subject": "e1",
"_value_raw": {
"type": "conditional",
"shares": "maximaal 24.717 Gewone Aandelen",
"condition": "uitoefening van de 2026 BIS ESOP Inschrijvingsrechten",
"max_amount": "vermenigvuldiging van het aantal uitgeoefende 2026 BIS ESOP Inschrijvingsrechten met de uitoefeningsprijs"
}
},
{
"type": "officer_resignation",
"quote": "De vergadering neemt kennis van en aanvaardt het ontslag van de volgende bestuurder: - Impala Consulting Comm.V, vertegenwoordigd door Alexander Demoulin",
"value": {
"role": "bestuurder"
},
"object": null,
"subject": "e2",
"_value_raw": {
"role": "bestuurder",
"representative": "Alexander Demoulin"
}
},
{
"date": "2026-07-29",
"type": "officer_appointment",
"quote": "De vergadering beslist om te benoemen tot bestuurder en dit voor een termijn van 6 jaar: - De besloten vennootschap \u201CALTHUARDE LIFE SCIENCES\u201D",
"value": {
"role": "bestuurder",
"term": "6 jaar",
"start_date": "2026-07-29"
},
"object": null,
"subject": "e4",
"_value_raw": {
"role": "bestuurder",
"term": "6 jaar",
"start_date": "29-07-2026"
}
},
{
"type": "permanent_representative",
"quote": "ALTHUARDE LIFE SCIENCES ... vast vertegenwoordigd door de heer Roderick Verhelst ... als Investeerder Bestuurder",
"value": {
"role": "Investeerder Bestuurder"
},
"object": "e4",
"subject": "e5"
},
{
"type": "mandate_compensation",
"quote": "Hun mandaat zal onbezoldigd zijn.",
"value": "onbezoldigd",
"object": null,
"subject": "e4"
},
{
"type": "subscription_right_cancellation",
"quote": "De vergadering beslist tot vernietiging van 15 anti-dilutie inschrijvingsrechten uitgegeven door de buitengewone algemene vergadering van de Vennootschap van 27 mei 2025",
"value": {
"type": "Anti-Dilutie Inschrijvingsrechten",
"count": "15",
"status": "niet-toegekend",
"issued_date": "27 mei 2025"
},
"object": null,
"subject": "e1"
},
{
"type": "subscription_right_cancellation",
"quote": "De vergadering beslist tot vernietiging van 15.481 inschrijvingsrechten, waarvan (i) 4.372 inschrijvingsrechten werden uitgegeven door de buitengewone algemene vergadering van de Vennootschap van 11 december 2020, (ii) 2.468 inschrijvingsrechten werden uitgegeven door de buitengewone algemene vergadering van de Vennootschap van 27 mei 2025, en (iii) 8.641 inschrijvingsrechten werden uitgegeven door de buitengewone algemene vergadering van de Vennootschap van 5 maart 2026",
"value": {
"type": "ESOP Inschrijvingsrechten",
"count": "15.481",
"status": "niet-toegekend",
"breakdown": [
{
"date": "11 december 2020",
"count": "4.372"
},
{
"date": "27 mei 2025",
"count": "2.468"
},
{
"date": "5 maart 2026",
"count": "8.641"
}
]
},
"object": null,
"subject": "e1"
},
{
"type": "board_authorization",
"quote": "De vergadering beslist met betrekking tot de 2026 BIS ESOP Inschrijvingsrechten uitgegeven in het kader van het \u2018Aandelenoptieplan 2026 BIS\u2019 alle machten te verlenen aan de raad van bestuur teneinde, in overeenstemming met de uitgiftevoorwaarden van voormeld inschrijvingsrechtenplan, de identiteit van de begunstigden vast te stellen en het aantal aan hen aangeboden 2026 BIS ESOP Inschrijvingsrechten en de uitoefenprijs daarvan.",
"value": {
"plan": "Aandelenoptieplan 2026 BIS",
"scope": "vaststelling identiteit begunstigden, aantal aangeboden 2026 BIS ESOP Inschrijvingsrechten en uitoefenprijs",
"mandatary": "raad van bestuur"
},
"object": null,
"subject": "e1"
}
],
"act_meta": {
"outcome": "corrected",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 9963,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "1012.800.853",
"kind": "company",
"name": "SPICA THERAPEUTICS",
"attrs": {
"seat": "Uitbreidingstraat 66 bus 3, 2600 Antwerpen",
"legal_form": "Naamloze vennootschap"
}
},
{
"id": "e2",
"kbo": null,
"kind": "company",
"name": "Impala Consulting Comm.V",
"attrs": {}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Alexander Demoulin",
"attrs": {}
},
{
"id": "e4",
"kbo": "0778.398.769",
"kind": "company",
"name": "ALTHUARDE LIFE SCIENCES",
"attrs": {
"seat": "Sint-Niklaasstraat 25, 3321 Hoegaarden",
"legal_form": "besloten vennootschap"
}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Roderick Verhelst",
"attrs": {
"birth_date": "1985-07-05",
"birth_place": "Leuven"
}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Tim CARNEWAL",
"attrs": {
"address": "Lloyd Georgelaan 11, 1000 Brussel"
}
}
]
}13-03-2026 Articles of association amended, translation of the articles, coordination of the articles and amendment of specific articles
Technical details
{
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2026-03-13",
"filing_date": "2026-03-11",
"act_kind_objet": "KAPITAAL, AANDELEN, STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN)"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2026-03-05",
"unanimous": null
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"targeted_amendment"
],
"scope": "full_restatement",
"trigger": "capital_change_consequence",
"language_after": null,
"language_before": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "1012.800.853",
"name_full_after": "SPICA THERAPEUTICS",
"legal_form_after": "Naamloze vennootschap",
"name_full_before": "SPICA THERAPEUTICS",
"current_zetel_raw": "Uitbreidingstraat 66 bus 3 2600 Antwerpen",
"legal_form_before": "Naamloze vennootschap"
},
"special_mandates": [],
"articles_modified": [
{
"summary": "Vervanging van artikel 5 van de statuten met de nieuwe kapitaalwaarde.",
"new_text": "Het kapitaal van de vennootschap bedraagt tien miljoen achthonderdzevenentachtigduizend tweehonderdeenenvijftig euro vierenveertig cent (\u20AC 10.887.251,44).",
"change_kind": "replaced",
"article_title": null,
"article_number": "5"
}
],
"governance_change": {
"organ_kind_after": null,
"organ_kind_before": null,
"admin_delegated_added": [],
"representation_rule_after": null,
"co_signature_threshold_eur": null,
"representation_rule_before": null
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tim CARNEWAL",
"org_rep_person_name": null
},
"co_filed_documents": [
"een uitgifte van het proces-verbaal",
"drie volmachten",
"de geco\u00F6rdineerde tekst van statuten",
"het aandelenoptieplan",
"het verslag van de raad van bestuur",
"het verslag van de commissaris opgesteld in toepassing van artikel 7:155 van het Wetboek van vennootschappen en verenigingen",
"het verslag van de raad van bestuur en het verslag van de commissaris opgesteld in toepassing van artikel 7:180, tweede lid van het Wetboek van vennootschappen en verenigingen"
],
"shareholder_rights": {
"quorum_rules_changed": false,
"liquidation_preference_text": null,
"voorkeurrecht_rules_changed": true,
"aandelenoverdracht_restrictions_changed": false
},
"voorwerp_change_summary": null,
"capital_structure_change": {
"operations": [
"capital_increase_cash",
"share_class_creation"
],
"split_ratio": null,
"shares_after": 235854,
"shares_before": null,
"capital_after_eur": 10887251.44,
"capital_before_eur": 8887251.44,
"share_classes_after": [
{
"count": 114205,
"label": "Gewone Aandelen",
"rights_summary": "Deel in winsten pro rata temporis vanaf inschrijving",
"voting_per_share": null
},
{
"count": 121649,
"label": "Seed Aandelen",
"rights_summary": "Deel in winsten pro rata temporis vanaf inschrijving",
"voting_per_share": null
}
]
},
"coordinated_text_lineage": null
}11-06-2025 Registered office moved from Brussel to Berchem
- Barricadenplein 13, 1000 Brussel → Uitbreidingsstraat 66, 2600 Berchem
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Berchem",
"region": "Vlaams Gewest",
"street": "Uitbreidingsstraat",
"country": "BE",
"postcode": "2600",
"box_number": "3",
"street_number": "66"
},
"old_address": {
"city": "Brussel",
"region": "Brussels Gewest",
"street": "Barricadenplein",
"country": "BE",
"postcode": "1000",
"box_number": null,
"street_number": "13"
},
"effective_date": "2025-05-27",
"evidence_quote": "De vergadering beslist de zetel te verplaatsen naar het Vlaamse Gewest, te 2600, Berchem, Uitbreidingsstraat 66 bus 3, met ingang vanaf zevenentwintig mei tweeduizend vijfentwintig."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1012.800.853",
"name_full": "SPICA THERAPEUTICS",
"legal_form": "NV"
}
}12-05-2025 3 directors appointed
- Jim Van heusden, Bestuurder
- James Rush, Bestuurder
- Alexander Demoulin, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jim Van heusden",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0525916875",
"name": "bioskills BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-05-12",
"evidence_quote": "De algemene vergadering benoemt bioskills BV, Stationsstraat 132, box 3, 9250 Waasmunster, RPR 0525.916.875, vast vertegenwoordigd door de heer Jim Van heusden, als onafhankelijk bestuurder. Dit mandaat start vanaf heden en loopt voor een periode van 3 jaar, tot de algemene vergadering die beslist o"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "James Rush",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Triangulate GmbH",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-05-12",
"evidence_quote": "De algemene vergadering benoemt Triangulate GmbH, Barmettlenstrasse 45, 6390, Engelberg, Zwitserland, vast vertegenwoordigd door de heer James Rush tot CEO bestuurder. Dit mandaat start vanaf heden en loopt voor een periode van 3 jaar, tot de algemene vergadering die beslist over de jaarrekening van"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Alexander Demoulin",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0777689778",
"name": "Impala Consulting CommV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-05-12",
"evidence_quote": "De algemene vergadering beslist om Impala Consulting CommV, Fourmentstraat 20, 2018 Antwerpen, RPR 0777689778, vast vertegenwoordigd door Alexander Demoulin, te benoemen tot Investeerder Bestuurder. Dit mandaat start vanaf heden en loopt voor een periode van 3 jaar, tot de algemene vergadering die b"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1012.800.853",
"name_full": "SPICA THERAPEUTICS",
"legal_form": "NV"
}
}19-12-2024 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": null,
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2024-12-19",
"filing_date": "2024-12-17",
"act_kind_objet": "DIVERSEN"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-12-11",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "1012.800.853",
"name": "SPICA THERAPEUTICS",
"role": "contributor",
"address": "Barricadenplein 13, 1000 Brussel",
"is_foreign": false,
"legal_form": "Naamloze vennootschap",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [
"7:180"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": null,
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "1012.800.853",
"name_full": "SPICA THERAPEUTICS",
"legal_form": "Naamloze vennootschap"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tim CARNEWAL",
"org_rep_person_name": null
},
"summary_narrative": "De buitengewone algemene vergadering van SPICA THERAPEUTICS heeft besloten tot de uitgifte van ESOP- en Anti-dilutie-inschrijvingsrechten, een kapitaalverhoging in geld, en de benoeming van een commissaris.",
"co_filed_documents": [
"een uitgifte van het proces-verbaal",
"\u00E9\u00E9n volmacht",
"de verslagen van de raad van bestuur",
"de verslagen van de commissaris"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "capital_shares"
}| Legal nameNL | SPICA THERAPEUTICS |